ABHD5 and colorectal carcinoma: It has been reported that the lipolysis factor ABHD5 can interact with DPY30 in the cytoplasm, thereby inhibiting the nuclear translocation of DPY30 and reducing the activity of SET1A and the dryness of CRC cells [45].